# RETRACTION: Long Non‐Coding RNA FEZF1‐AS1 Induced Progression of Ovarian Cancer via Regulating miR‐130a‐5p/SOX4 Axis

PMC · DOI: 10.1111/jcmm.71043 · 2026-01-28

## TL;DR

This retracted study claimed that a specific non-coding RNA promotes ovarian cancer progression through a molecular pathway involving miR-130a-5p and SOX4.

## Contribution

The paper proposed a novel regulatory mechanism involving FEZF1-AS1, miR-130a-5p, and SOX4 in ovarian cancer progression.

## Key findings

- FEZF1-AS1 was suggested to regulate ovarian cancer progression via the miR-130a-5p/SOX4 axis.
- The study reported image duplications and manipulations from multiple previously published articles.
- The retraction was agreed upon due to evidence of image reuse compromising the study's credibility.

## Abstract

RETRACTION: 
SunZ.
, 
GaoS.
, 
XuanL.
, and 
LiuX.
, “Long Non‐Coding RNA FEZF1‐AS1 Induced Progression of Ovarian Cancer via Regulating miR‐130a‐5p/SOX4 Axis,” Journal of Cellular and Molecular Medicine
24, no. 7 (2020): 4275–4285. 10.1111/jcmm.15088.32135030
PMC7171310

The above article, published online on 05 March 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor‐in‐Chief, Stefan Constantinescu; and John Wiley & Sons Ltd. A third party reported multiple instances of image duplications between this article and previously published articles. All images in Figure 2C had previously been published in [Zhu et al. 2019 (https://doi.org/10.1038/s41467‐023‐41612‐z)] and reported as different samples. All images in Figures 3A, 3B, 4C, and 4D had previously been published in Li et al. 2017 [(https://doi.org/10.1038/cddis.2017.119)] and reported as different samples. The GAPDH band in Figure 5D and all bands in Figure 5H had previously been published in [Liu et al. 2017 (https://doi.org/10.1186/s12943‐017‐0625‐8)] and all those images were manipulated and rotated. Furthermore, multiple images in Figure 5E had previously been published in Liu et al. 2017, where further manipulation and rotation had been applied to these images.

An investigation by the publisher confirmed these concerns and discovered additional instances of image duplication from other articles. Data in Figure 2D had previously been published in [Liang et al. 2018 (https://doi.org/10.1038/s41419‐018‐0582‐1)], [Wang et al. 2019 (https://doi.org/10.18632/aging.102081)] and [Liang et al. 2020 (https://doi.org/10.1186/s12943‐020‐01206‐5)]. Images in Figure 2C had previously been published in [Zhu et al. 2019 (https://doi.org/10.1038/s41467‐018‐07998‐x)] and these images had been rotated. Multiple images in Figure 5E that were also previously published in Liu et al. 2017, were also later published in [Li et al. 2021 (https://doi.org/10.2147/OTT.S302800)].

The retraction has been agreed to because the evidence of image re‐use and manipulation with multiple previously published articles fundamentally compromises the editors’ confidence in the results presented. The authors did not respond to our notice regarding the retraction.

## Linked entities

- **Genes:** FEZF1-AS1 (FEZF1 antisense RNA 1) [NCBI Gene 154860], SOX4 (SRY-box transcription factor 4) [NCBI Gene 6659]
- **Diseases:** ovarian cancer (MONDO:0005140)

## Full-text entities

- **Genes:** FEZF1-AS1 (FEZF1 antisense RNA 1) [NCBI Gene 154860], SOX4 (SRY-box transcription factor 4) [NCBI Gene 6659] {aka CSS10, EVI16, IDDSDF}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}
- **Diseases:** Ovarian Cancer (MESH:D010051)

---
Source: https://tomesphere.com/paper/PMC12852960